CLVS

Clovis Oncology, Inc. News Headlines

$77.4
*  
1.85
2.45%
Get CLVS Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading CLVS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CLVS Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Earnings Reported After The Bell Feb. 25
2/26/2015 5:25:00 AM - RTT News


Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
2/20/2015 9:00:00 AM - Seeking Alpha


InsiderInsights.com Daily Round Up 1/20/15: WIW, WIA, OPK, MLNK
1/21/2015 8:39:00 AM - Seeking Alpha


Clovis Oncology, Inc. (CLVS) in Focus: Stock Jumps 5.9% - Tale of the Tape
1/14/2015 9:18:00 AM - Zacks.com


Clovis Oncology Inc. (CLVS) Has Spiked To The Upside
1/13/2015 9:55:00 AM - RTT News


AstraZeneca's Lynparza Approved in EU for Ovarian Cancer - Analyst Blog
12/19/2014 4:48:00 PM - Zacks.com


AstraZeneca's Lynparza Approved in EU for Ovarian Cancer - Analyst Blog
12/19/2014 4:48:00 AM - Investopedia


CO-1686 Data Confirmed Efficacy, Take Advantage Of Weakness In Clovis Oncology Shares Ahead Of Rucaparib Outcomes Data
11/19/2014 11:41:00 AM - Seeking Alpha


Clovis Oncology (CLVS) Shares Cross Below 200 DMA
11/17/2014 4:33:41 PM - BNK Invest


AstraZeneca's Lynparza a Step Closer to European Approval - Analyst Blog
10/27/2014 4:41:00 PM - Zacks.com


3 Beaten Down Biotech Stocks to Buy Now
10/23/2014 10:20:03 AM - Motley Fool


Big News for These 5 Stocks From ESMO
9/30/2014 8:05:02 AM - Motley Fool


CLVS January 2016 Options Begin Trading
9/4/2014 10:46:38 AM - BNK Invest


Clovis Oncology (CLVS) Falls: Stock Goes Down 6.8% - Tale of the Tape
9/4/2014 7:43:00 AM - Zacks.com


Sector Update: Health-Care Stocks Mixed Pre-Market
9/4/2014 7:18:34 AM - MT Newswires


Sector Update: Health Care
9/4/2014 7:14:34 AM - MT Newswires


Competition And Momentum Weighing On Clovis Oncology
8/23/2014 7:15:00 AM - Seeking Alpha


Interesting CLVS Put And Call Options For August 16th
6/25/2014 11:19:57 AM - BNK Invest


Clovis Oncology Initiates Study on CO-1686 - Analyst Blog
6/24/2014 10:40:00 AM - Zacks.com


Sector Update: Healthcare
6/23/2014 7:59:31 AM - MT Newswires


Sector Update: Healthcare Shares Mixed Pre-Market; AbbVie Lifts on Fiscal 2014 Guidance
6/23/2014 7:58:31 AM - MT Newswires


Clovis Oncology (CLVS) Jumps: Stock Rises 6.2% - Tale of the Tape
6/6/2014 7:51:00 AM - Zacks.com


Sector Update: Technology Shares Flat Pre-Market; Clovis Oncology Upgraded to Buy at Stifel Nicolaus
6/5/2014 7:29:35 AM - MT Newswires


Sector Update: Healthcare Healthcare
6/5/2014 7:28:19 AM - MT Newswires


Monday Sector Laggards: Drugs, Manufacturing Stocks
6/2/2014 2:44:31 PM - BNK Invest